Glycyrrhetinic acid modulates the STAT3-HIF-1α pathway in macrophages, enhancing autophagy flux impairment. This mitigates the excessive generation of inflammatory cytokines and hepatocyte apoptosis, thereby alleviating the progression of NAFLD. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatotic liver disease.